参考文献/References:
[1]Ouyang Q,Tian C,Gao J,et al.HER2-positive double primary tumor of gastric and breast cancer occur synchronously in a patient:A case report[J].Mole Clin Oncol,2016,4(5):719-722.[2]Schuell B,Gruenberger T,Scheithauer W,et al.HER2/neu protein expression in colorectal cancer[J].BMC Cancer,2006(6):123.[3]Eltze E,Wulfing C,Von Struensee D,et al.Cox-2 and Her2/neu co-expression in invasive bladder cancer[J].Int J Oncol,2005,26(6):1525-1531.[4]Ross JS,Fletcher JA.HER-2/neu(c-erb-B2)gene and protein in breast cancer[J].Am J Clin Pathol,1999,112(1 Suppl 1):S53-S67.[5]胃癌HER2检测指南编写组.胃癌HER2检测指南[J].中华病理学杂志,2011,40(8):553-557.[6]Zhou C,Feng X,Yuan F,et al.Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis[J].Cancer Manag Res,2018(10):3945-3954.[7]Lei YY,Huang JY,Zhao QR,et al.The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients:a meta-analysis of literature[J].World J Surg Oncol,2017,15(1):68.[8]Ramsauer VP,Carraway CA,Salas PJ,et al.Muc4/sialomiucin complex,the intramembrane ErbB2 ligand,translocates ErbB2 to the apical surface in polarized epithelial cell[J].J Biol Chem,2003,278(32):30142-30147.[9]Hausherr CK,Schiffer IB,Gebhard S,et al.Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER2 and Raf1 blocking therapy in a conditional mouse tumor model[J].Mol Carcinog,2006,45(5):302-308.[10]McCubrey JA,Steelman LS,Abrams SL,et al.Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance[J].Advan Enzyme Regul,2006(46):249-279.[11]Van Cutsem E,Bang YJ,Feng-Yi F,et al.HER2 screening data from ToGA:targeting HER2 in gastric and gastroesophageal junction cancer[J].Gastric Cancer,2015,18(3):476-484.[12]Gravalos C,Jimeno A.HER2 in gastric cancer:a new prognostic factor and a novel therapeutic target[J].Ann Oncol,2008,19(9):1523-1529.[13]胃癌HER2检测指南编写组.胃癌HER2检测指南[J].中华病理学杂志,2016,45(8):528-532.
相似文献/References:
[1]杜秋越,刘易欣,陈 凌.免疫组化指标在宫颈微偏腺癌诊断中的应用[J].医学信息,2018,31(09):53.[doi:10.3969/j.issn.1006-1959.2018.09.017]
DU Qiu-yue,LIU Yi-xin,CHEN Ling.Application of Immunohistochemical Markers in Diagnosis of Minimal Deviationadenocarcinoma of Cervix[J].Medical Information,2018,31(13):53.[doi:10.3969/j.issn.1006-1959.2018.09.017]
[2]张小龙.P53在胆囊癌临床预后中的预测意义[J].医学信息,2018,31(11):156.[doi:10.3969/j.issn.1006-1959.2018.11.051]
ZHANG Xiao-long.Predictive Significance of P53 in Clinical Prognosis of Gallbladder Carcinoma[J].Medical Information,2018,31(13):156.[doi:10.3969/j.issn.1006-1959.2018.11.051]
[3]张晓玲.替吉奥联合多西他赛治疗转移性乳腺癌的临床疗效观察[J].医学信息,2018,31(20):128.[doi:10.3969/j.issn.1006-1959.2018.20.038]
ZHANG Xiao-ling.Clinical Observation of Tegafur,Gimeracil and Oteracil Porassium Capsules Combined with Docetaxel in the Treatment of Metastatic Breast Cancer[J].Medical Information,2018,31(13):128.[doi:10.3969/j.issn.1006-1959.2018.20.038]
[4]王晓娇,练孝春,刘正人.埃兹蛋白在乳腺癌中的表达及其临床意义[J].医学信息,2019,32(21):88.[doi:10.3969/j.issn.1006-1959.2019.21.027]
WANG Xiao-jiao,LIAN Xiao-chun,LIU Zheng-ren.Expression of Ezrin in Breast Cancer and Its Clinical Significance[J].Medical Information,2019,32(13):88.[doi:10.3969/j.issn.1006-1959.2019.21.027]
[5]沈国菊,徐嘉忆,彭 川,等.消化道炎性纤维性息肉临床病理分析[J].医学信息,2019,32(22):154.[doi:10.3969/j.issn.1006-1959.2019.22.053]
SHEN Guo-ju,XU Jia-yi,PENG Chuan,et al.Clinicopathological Analysis of Gastrointestinal Inflammatory Fibrous Polyps[J].Medical Information,2019,32(13):154.[doi:10.3969/j.issn.1006-1959.2019.22.053]
[6]张秀梅,侯兴华,赵俊军.卵巢Sertoli细胞瘤临床病理特征分析[J].医学信息,2020,33(02):176.[doi:10.3969/j.issn.1006-1959.2020.02.057]
ZHANG Xiu-mei,HOU Xing-hua,ZHAO Jun-jun.Analysis of Clinicopathological Characteristics of Ovarian Sertoli Cell Tumor[J].Medical Information,2020,33(13):176.[doi:10.3969/j.issn.1006-1959.2020.02.057]
[7]向青林,张 伟.HER2、EGFR、VEGFR在胃印戒细胞癌中的表达及其临床意义[J].医学信息,2020,33(06):87.[doi:10.3969/j.issn.1006-1959.2020.06.025]
XIANG Qing-lin,ZHANG Wei.Expression of HER2,EGFR and VEGFR in Gastric Signet Ring Cell Carcinoma and Its Clinical Significance[J].Medical Information,2020,33(13):87.[doi:10.3969/j.issn.1006-1959.2020.06.025]
[8]王羽翎,孙佳威,周显礼.二维及三维实时剪切波弹性成像在乳腺肿块评估中的应用[J].医学信息,2020,33(11):42.[doi:10.3969/j.issn.1006-1959.2020.11.014]
WANG Yu-ling,SUN Jia-wei,ZHOU Xian-li.Application of 2D and 3D Real-time Shear Wave Elastography in Breast Mass Evaluation[J].Medical Information,2020,33(13):42.[doi:10.3969/j.issn.1006-1959.2020.11.014]
[9]冯 洁,陈红莉,唐建光,等.FGFR2、HER2和PTEN在胃癌组织中的表达及临床意义[J].医学信息,2020,33(23):92.[doi:10.3969/j.issn.1006-1959.2020.23.026]
FENG Jie,CHEN Hong-li,TANG Jian-guang,et al.Expression and Clinical Significance of FGFR2、HER2 and PTEN in Gastric Cancer[J].Medical Information,2020,33(13):92.[doi:10.3969/j.issn.1006-1959.2020.23.026]
[10]周 梅,赵 刚,禤瑞霞,等.鼻咽癌中IKKβ和Ki-67的表达与肿瘤侵袭转移的关系[J].医学信息,2022,35(17):22.[doi:10.3969/j.issn.1006-1959.2022.17.005]
ZHOU Mei,ZHAO Gang,XUN Rui-xia,et al.Expression of IKKβ and Ki-67 in Nasopharyngeal Carcinoma and its Relationship with Tumor Invasion and Metastasis[J].Medical Information,2022,35(13):22.[doi:10.3969/j.issn.1006-1959.2022.17.005]